Fortrea rescued a Phase III hypercholesterolemia trial enrollment by using pre-screening logs and targeted site interventions to reduce screen...

Masimo smartSET gains FDA clearance for AFib and opioid depression detection, adding AI-driven pattern recognition to pulse oximetry monitoring.

XS411 Parkinson's cell therapy demonstrated five hours of daily ON-time gain in Phase I, with no serious adverse events...

Base editing reached human trials, but the FDA's April 2026 NGS safety draft guidance reveals how far the regulatory...

24/7 ICU staffing emerges as critical factor in ARDS trial enrollment, with site selection now prioritizing round-the-clock research availability.

Evident launches Pramana POD scanner for small pathology labs, processing 25 slides per hour with built-in quality assessment to...

Payers report inconsistent ESR1 testing practices for advanced breast cancer, creating delays in targeted SERD treatment despite clinical evidence...

AHN Cancer Center launches RANDY'S Trial to test FDA-approved drugs for treating peritoneal fibrosis in abdominal cancer patients.

FDA Approves RYZUMVI for presbyopia treatment in adults. Viatris seeks commercial partner to bring the phentolamine eye drop to...

OptiTROP-Lung05's HR of 0.35 over pembrolizumab monotherapy looks decisive, until you ask whether that comparator still reflects standard of...